CVS Group (LON:CVSG) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

CVS Group plc (LON:CVSG) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,247.81 and traded as low as GBX 1,170. CVS Group shares last traded at GBX 1,173, with a volume of 136,403 shares.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CVSG shares. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 1,900 target price on shares of CVS Group in a report on Thursday, March 5th. Berenberg Bank restated a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research report on Tuesday, May 26th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of GBX 1,724.

CVS Group Trading Up 3.8%

The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. The business has a fifty day simple moving average of GBX 1,191.40 and a 200 day simple moving average of GBX 1,247.79. The stock has a market capitalization of £864.09 million, a price-to-earnings ratio of 17.92, a price-to-earnings-growth ratio of 1.77 and a beta of 1.04.

CVS Group announced that its Board of Directors has initiated a share buyback plan on Tuesday, May 26th that allows the company to repurchase 0 shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

Insider Activity at CVS Group

In other CVS Group news, insider Scott Morrison purchased 987 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The shares were acquired at an average cost of GBX 1,270 per share, for a total transaction of £12,534.90. Company insiders own 1.43% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.